Csarnok Óceánia hardver sakre sclc elviselni kulacs Halálos
Cancers | Free Full-Text | Transcriptional Profiling Reveals Mesenchymal Subtypes of Small Cell Lung Cancer with Activation of the Epithelial-to-Mesenchymal Transition and Worse Clinical Outcomes
PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer | Cancer Pathogenesis and Therapy
Cancers | Free Full-Text | Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR | Oncotarget
Simultaneously targeting DNA damage repair pathway and mTORC1/2 results in small cell lung cancer growth arrest via ER stress-induced apoptosis
A multiplexed in vivo approach to identify driver genes in small cell lung cancer | bioRxiv
Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations
Nneha Sakre PhD - Biosafety Specialist II - Stanford University | LinkedIn
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate - ScienceDirect
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications: Molecular Therapy - Oncolytics
YAP1 promotes multidrug resistance of small cell lung cancer by CD74‐related signaling pathways - Song - 2020 - Cancer Medicine - Wiley Online Library
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis | Oncogene
Cancers | Free Full-Text | Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer
Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers - ScienceDirect
A multiplexed in vivo approach to identify driver genes in small cell lung cancer - ScienceDirect
YAP1 promotes multidrug resistance of small cell lung cancer by CD74‐related signaling pathways - Song - 2020 - Cancer Medicine - Wiley Online Library
YAP drives fate conversion and chemoresistance of small cell lung cancer | Science Advances
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization - ScienceDirect
Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma | Science Advances
Frontiers | Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer
JCM | Free Full-Text | Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research
Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma | Science Advances
SCLC YAP1 Subtype: Potential for Personalized Therapy? - Small Cell Lung Cancer: Contemporary Concepts
Cancers | Free Full-Text | Pathology and Classification of SCLC
Cancers | Free Full-Text | Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer
Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer | Science Advances